Guidance on the appointment of assessors and co-assessors for Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC)
The Member State Coordination Group on Health Technology Assessment adopted on 28 November 2024 this guidance on the appointment of assessors and co-assessors for joint clinical assessment and joint scientific consultation, including on the scientific expertise required, pursuant to Art. 3(7g) of the Health Technology Assessment Regulation (Regulation (EU) 2021/2282).
The present guidance:
• defines the procedure for the appointment of assessor and co-assessor;
• sets minimum requirements for the appointment of the assessor and co-assessor for JCAs and JSCs for medicinal products and medical devices and in vitro diagnostic medical devices.
Read the background document published by Directorate-General for Health and Food Safety on 28 November 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (12 janvier 2025). Guidance on the appointment of assessors and co-assessors for Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC). ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/132dl





